Raffaele Piccolo (@piccoloraf) 's Twitter Profile
Raffaele Piccolo

@piccoloraf

Associate Professor @uninaIT | Interventional Cardiologist, MD, PhD | Focus: Coronary and Vascular Interventions | Tweets are my opinion & not medical advices

ID: 1387598426

calendar_today28-04-2013 18:28:34

1,1K Tweet

1,1K Followers

587 Following

Jamie Lewis (@lewischemistry) 's Twitter Profile Photo

We have a 3-year postdoc position available, starting in October, to work on molecular capsules for catalysis. Click on the link below to apply! 👇 Happy to have informal chats about the post - send me an email. Application deadline 6 July. edzz.fa.em3.oraclecloud.com/hcmUI/Candidat…

JACC Journals (@jaccjournals) 's Twitter Profile Photo

In 1-year outcomes of the TRAVEL study, transcatheter tricuspid valve replacement with LuX-Valve resulted in sustained ⬇️ in TR, significant right heart reverse remodeling & improved functional status. jacc.org/doi/10.1016/j.… #JACCINT #TTVR #vhdTR Univ.-Prof. Dr. Ralph Stephan von Bardeleben

In 1-year outcomes of the TRAVEL study, transcatheter tricuspid valve replacement with LuX-Valve resulted in sustained ⬇️ in TR, significant right heart reverse remodeling & improved functional status. jacc.org/doi/10.1016/j.…

#JACCINT #TTVR #vhdTR <a href="/vonBardelebenRS/">Univ.-Prof. Dr. Ralph Stephan von Bardeleben</a>
Marco Spagnolo (@marcospagnolo21) 's Twitter Profile Photo

P2Y₁₂ pre-treatment may be considered in STEMI, but achieving rapid and potent platelet inhibition is often hindered by the patient's conditions. In such cases, alternative administration routes should be considered. Novel agents may help overcome these issues. #GISESicilia

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

I am pleased to announce that the new Impact Factor of EuroIntervention is the highest in its 20-year history: 9.5. Ranked 16th out of 230 journals in the cardiovascular category (+5 positions versus the previous year). Thank you all — it’s an exciting rollercoaster.

I am pleased to announce that the new Impact Factor of EuroIntervention is the highest in its 20-year history: 9.5. Ranked 16th out of 230 journals in the cardiovascular category (+5 positions versus the previous year). Thank you all — it’s an exciting rollercoaster.
Sylvie Lhoste (@syllho) 's Twitter Profile Photo

Our predictions were correct! EuroIntervention has reached an IF of 9.5 and is the 1st interventional journal in Scopus CiteScore with 12.2. I am so proud of my team, so grateful to work with Davide Capodanno and thankful to our community! #CardioX

Our predictions were correct! <a href="/EuroInterventio/">EuroIntervention</a> has reached an IF of 9.5 and is the 1st interventional journal in Scopus CiteScore with 12.2. I am so proud of my team, so grateful to work with <a href="/DFCapodanno/">Davide Capodanno</a> and thankful to our community! #CardioX
Felice Gragnano (@felicegragnano) 's Twitter Profile Photo

💡 In PCI patients who had discontinued DAPT, P2Y12 inhibitor monotherapy was associated with lower MACCE compared with aspirin, without an increased risk of bleeding. Read more in The BMJ 🔗 bmj.com/content/389/bm… Marco Valgimigli Daniele Giacoppo PCRonline 🫀 TCTMD theheartorg | Medscape

💡 In PCI patients who had discontinued DAPT, P2Y12 inhibitor monotherapy was associated with lower MACCE compared with aspirin, without an increased risk of bleeding. Read more in <a href="/bmj_latest/">The BMJ</a> 
🔗 bmj.com/content/389/bm…

<a href="/vlgmrc/">Marco Valgimigli</a> <a href="/DanieleGiacoppo/">Daniele Giacoppo</a> <a href="/PCRonline/">PCRonline 🫀</a> <a href="/TCTMD/">TCTMD</a> <a href="/theheartorg/">theheartorg | Medscape</a>
Gregg W. Stone MD (@greggwstone) 's Twitter Profile Photo

Our new PROSPECT II study in Circulation comparing untreated non-obstructive lsns in STEMI & NSTEMI. ~4 such lsns per pt. 2-feature high-risk plaques were equally present (in 38.8% vs. 32.7%; P=0.11). 4-yr rates of untreated lesion-related MACE were also similar (8.6% vs 7.8%).

Our new PROSPECT II study in Circulation comparing untreated non-obstructive lsns in STEMI &amp; NSTEMI. ~4 such lsns per pt. 2-feature high-risk plaques were equally present (in 38.8% vs. 32.7%; P=0.11). 4-yr rates of untreated lesion-related MACE were also similar (8.6% vs 7.8%).
Barack Obama (@barackobama) 's Twitter Profile Photo

Independence Day is a reminder that America is not the project of any one person. The single most powerful word in our democracy is the word ‘We.’ ‘We The People.’ ‘We Shall Overcome.’ ‘Yes We Can.’ America is owned by no one. It belongs to all citizens. And at this moment in

CiroCala79 (@cica7981) 's Twitter Profile Photo

💙 #5luglio 1984💙 Davanti ad un "San Paolo" strapieno si presenta il calciatore più forte di tutti i tempi. "Buona sera napoletani",sono le sue prime parole. Inizia così la favola più bella. Official SSC Napoli

Raffaele Piccolo (@piccoloraf) 's Twitter Profile Photo

In patients with acute stroke undergoing thrombolysis, tirofiban increased the likelihood of an excellent functional outcome. Just wondering whether tirofiban may have a role in primary PCI in the radial era. NEJM

In patients with acute stroke undergoing thrombolysis, tirofiban increased the likelihood of an excellent functional outcome. Just wondering whether tirofiban may have a role in primary PCI in the radial era.

<a href="/NEJM/">NEJM</a>
Tesfaye A. Telila MD, FACC,FSCAI. (@ttelila) 's Twitter Profile Photo

History Made in Ethiopia! 🇪🇹 I am incredibly proud to celebrate Heart Attack Ethiopia, Inc. Mission #4, our outstanding team, our Ethiopian medical partners, and the courageous patients and families who entrusted us with their care. Together, we successfully performed the first-ever

History Made in Ethiopia! 🇪🇹

I am incredibly proud to celebrate <a href="/HeartAEthiopia/">Heart Attack Ethiopia, Inc.</a> Mission #4, our outstanding team, our Ethiopian medical partners, and the courageous patients and families who entrusted us with their care.

Together, we successfully performed the first-ever
Heart Attack Ethiopia, Inc. (@heartaethiopia) 's Twitter Profile Photo

🌍 Day 3 - Addis Ababa, Ethiopia 🇪🇹 Third day in Ethiopia, today officially marks Day 1 of procedures for the incredible team behind Heart Attack Ethiopia’s fourth mission — and it’s set to be a milestone moment for cardiac care in the country. This morning’s medical briefing

Raffaele Piccolo (@piccoloraf) 's Twitter Profile Photo

New analysis showing >70% of patients undergoing TAVI with new brain lesions at 6 days. The phenomenon is not attenuated by antithrombotic strategy. I was wondering about the clinical relevance of such lesions as stroke rate is ~2-3%. EuroIntervention PCRonline 🫀 European Society of Cardiology

New analysis showing &gt;70% of patients undergoing TAVI with new brain lesions at 6 days. The phenomenon is not attenuated by antithrombotic strategy. I was wondering about the clinical relevance of such lesions as stroke rate is ~2-3%. 
<a href="/EuroInterventio/">EuroIntervention</a> <a href="/PCRonline/">PCRonline 🫀</a> <a href="/escardio/">European Society of Cardiology</a>
Thomas Pilgrim (@thompilgrim) 's Twitter Profile Photo

The inflammatory pathway offers a potential therapeutic target in patients undergoing #TAVR: in the Co-STAR trial, treatment with colchicine was associated with a lower risk of cardiac arrhythmias and subclinical leaflet thrombosis at 30 days. rdcu.be/ewfsl

The inflammatory pathway offers a potential therapeutic target in patients undergoing #TAVR: in the Co-STAR trial, treatment with colchicine was associated with a lower risk of cardiac arrhythmias and subclinical leaflet thrombosis at 30 days. rdcu.be/ewfsl